Share on LinkedInShare on LinkedIn

ARTICLE · 06 MARCH 2026

Federal Trade Commission Settlement With ESI

The past few weeks also brought an interesting settlement between the Federal Trade Commission (FTC) and Express Scripts, Inc. (Settlement).

United StatesEmployment and HR

The past few weeks also brought an interesting settlement between the Federal Trade Commission (FTC) and Express Scripts, Inc. (Settlement). The Settlement stems from the FTC's lawsuit against the three largest PBMs in the country (ESI, Caremark and OptumRx), along with related entities. The lawsuit focused on alleged anti-competitive practices related to insulin. However, the Settlement is much broader than that.

Plan sponsors will likely need to ask their PBM consultants how the required changes in the Settlement will impact their plan. Although the Settlement only involved ESI, plan sponsors might want to ask other PBMs (i.e., not just ESI) to "match" some of the terms in the Settlement. If PBMs agree to make such changes, the contracts between the PBMs and the plan sponsors will need to be updated. Note that the Settlement's terms have varying effective dates, but many of them will likely take effect in 2027.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from